11 results on '"Pappagallo, G."'
Search Results
2. 464 A randomized, open-label, multicentre study of efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate (HA 1.6% and CS 2%) vs dimethyl sulfoxide (DMSO 50%) in women with Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC)
3. P118 Preliminary results of HOPLITE trial, a factorial phase II randomized trial of continuous (C) or intermittent (I) docetaxel (D) ± estramustine (E) as first line treatment for castration resistant prostate cancer (CRPC)
4. Multiple Rechallenges for Castration-resistant Prostate Cancer Patients Responding to First-line Docetaxel: Assessment of Clinical Outcomes and Predictive Factors.
5. 966 Is there a difference in quality of life between BCG and intravesical chemotherapy? Results of a randomized phase II study
6. 305 RESULTS OF A MULTICENTRIC PHASE II RANDOMIZED TRIAL WITH DOCETAXEL (D) ± ESTRAMUSTINE (E) AS FIRST LINE CHEMOTHERAPY FOR PATIENTS (PTS) WITH HORMONE-REFRACTORY ADVANCED PROSTATE CANCER (HRPC)
7. PCN344 ADDITION OF PERTUZUMAB TO TRASTUZUMAB-BASED ADJUVANT THERAPY IN HIGH-RISK HER2-POSITIVE EARLY BREAST CANCER: A GRADE-BASED ANALYSIS FROM THE PHASE III APHINITY TRIAL.
8. 177 (PB-090) Poster - Residual Risk of Relapse: a Systematic Review and a Consensus Project on Unmet needs for HER2-positive non Metastatic Breast Cancer Patients.
9. The relevance of stable disease (SD) as a surrogate end-point in advanced non-small cell lung cancer (NSCLC) patients treated with erlotinib (E) as the second/third line
10. 7164 POSTER Adjuvant Treatment for Resected Renal Cell Carcinoma (RCC): Are All Strategies Equally Negative? Meta-analysis of Randomized Trials (RCTs)
11. 7050 POSTER Multiple Docetaxel (DOC) Re-challenges (ReC) in Castration-resistant Prostate Cancer (CRPC) Patients (pts) – Outcomes and Predictive Factors of Response
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.